Sumi. Fárm. Bioequivalente Crónicos Ambulatorios
Sumi. Fárm. Bioequivalente Crónicos Ambulatorios
19 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1058071-716-SE26 | 02-07-2026 | Winpharm SpA | $5.892.642 |
| 1058071-718-SE26 | 02-07-2026 | Pisa Farmaceutica de Chile SpA | $932.960 |
| 1058071-596-SE26 | 03-06-2026 | Winpharm SpA | $2.678.036 |
| 1058071-253-SE26 | 04-03-2026 | Laboratorios Andromaco S.A. | $585.480 |
| 1058071-2907-SE25 | 03-12-2025 | Opko Chile S.A. | $885.360 |
| 1058071-2737-SE25 | 03-10-2025 | Alembic Pharmaceuticals SpA | $751.842 |
| 1058071-2616-SE25 | 02-09-2025 | Alembic Pharmaceuticals SpA | $751.842 |
| 1058071-2416-SE25 | 04-07-2025 | Laboratorio Chile S.A. | $224.910 |
| 1058071-2299-SE25 | 05-06-2025 | Opko Chile S.A. | $4.714.756 |
| 1058071-2124-SE25 | 28-04-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $33.683.735 |
| 1058071-2118-SE25 | 22-04-2025 | Clinical Market S.A. | $18.217.710 |
| 1058071-2109-SE25 | 22-04-2025 | Opko Chile S.A. | $10.116.523 |
| 1058071-2113-SE25 | 22-04-2025 | Emcure Pharma Chile SpA | $1.738.269 |
| 1058071-2082-SE25 | 14-04-2025 | Emcure Pharma Chile SpA | $781.830 |
| 1058071-2055-SE25 | 02-04-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $6.738.768 |
| 1058071-1935-SE25 | 05-03-2025 | Laboratorios Andromaco S.A. | $15.232.000 |
| 1058071-1891-SE25 | 24-02-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $11.790.318 |
| 1058071-1793-SE25 | 22-01-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $13.477.535 |
Fuente original:ficha mercadopublico.cl
